Adrià Tort‐Merino

Biomedical Research Networking Center on Neurodegenerative Diseases

Also affiliated with Departament de Salut, Alzheimer’s Disease Neuroimaging Initiative, Hospital Clínic de Barcelona, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease”.

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease

NeuroImage Clinical(2021)10.1016/j.nicl.2021.102804

N/A

0DataRank · unranked

60 citations

Agnès Pérez‐Millan, Adrià Tort‐Merino, Mircea Balasa, Neus Falgàs, Jaume Olives +11 more

Characteristics of subjective cognitive decline associated with amyloid positivity

Alzheimer s & Dementia(2021)10.1002/alz.12512

N/A

0DataRank · unranked

54 citations

Willemijn J. Jansen, Stephanie J. B. Vos, Mercè Boada, Lucilla Parnetti, Tomasz Gabryelewicz +58 more

SCD‐plus features and AD biomarkers in cognitively unimpaired samples: A meta‐analytic approach for nine cohort studies

Alzheimer s & Dementia(2025)10.1002/alz.14307

N/A

0DataRank · unranked

11 citations

Hannah M Klinger, Rebecca E. Amariglio, Michael Wagner, Frank Jessen, Emrah Düzel +22 more

Development of amyloid‐negative neuropsychological norms using GAMLSS

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2025)10.1002/dad2.70224

N/A

0DataRank · unranked

2 citations

María Belén Sánchez‐Saudinós, Isabel Sala, Laura Videla, Alexandre Bejanin, Ainara Estanga +25 more

Amyloid‐negative neuropsychological norms: Added value in the era of biomarkers and disease‐modifying therapies

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2025)10.1002/dad2.70223

N/A

0DataRank · unranked

1 citations

Isabel Sala, María Belén Sánchez‐Saudinós, Laura Videla, Alexandre Bejanin, Ainara Estanga +25 more